Bioavailability Study of Vemurafenib in Participants With BRAF^V600 Mutation-Positive Malignancies
Clinical trial NCT02441465 · COMPLETED
Trial details
- NCT number
- NCT02441465
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-13
- Primary completion
- 2016-08-18
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.